Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.44 |
| ▸ | CTSL | P07711 | 4/20 | 0.44 |
| ▸ | CTSS | P25774 | 2/20 | 0.44 |
| ▸ | CTSK | P43235 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24786368 | 0.90 | L3MBTL1 (0.48) | L3MBTL1NAAALMNAPAX8GRIN1 | |
| SCHEMBL14279162 | 0.78 | L3MBTL1 (0.53) | L3MBTL1NAAAGRIN1GRIN2ACTSL | |
| SCHEMBL9915089 | 0.78 | GAA (0.48) | L3MBTL1LMNACTSL | |
| SCHEMBL506060 | 0.77 | NAAA (0.65) | L3MBTL1NAAAGRIA1HDAC3 | |
| SCHEMBL506059 | 0.77 | NAAA (0.65) | L3MBTL1NAAAGRIA1HDAC3 | |
| SCHEMBL10543883 | 0.75 | GRIA1 (0.71) | L3MBTL1CTSLCTSSCTSKGRIA1 | |
| SCHEMBL10543878 | 0.75 | GRIA1 (0.71) | L3MBTL1CTSLCTSSCTSKGRIA1 | |
| SCHEMBL7793390 | 0.75 | KMT2A (0.57) | L3MBTL1GRIN1GRIN2ACTSLCTSS | |
| SCHEMBL14279160 | 0.74 | NAAA (0.60) | L3MBTL1NAAAGRIN1GRIN2AGRIA1 | |
| SCHEMBL10073683 | 0.73 | CTSL (0.49) | CTSLCTSSCTSKCTSBHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220401554-A1 | USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES | CORNELL UNIVERSITY | 2022-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401554-A1 | USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES | PIGS, VMA21, FURIN | L3MBTL1 4157/4885NAAA 428/4885LMNA 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.